HIV-1 Tat inhibits IL-2 gene transcription through qualitative and quantitative alterations of the cooperative Rel/AP1 complex bound to the CD28RE/AP1 composite element of the IL-2 promoter

J Immunol. 2001 Apr 1;166(7):4560-9. doi: 10.4049/jimmunol.166.7.4560.

Abstract

Dysregulation of cytokine secretion plays an important role in AIDS pathogenesis. Here, we demonstrate that expression of HIV-1 Tat protein in Jurkat cells induces a severe impairment of IL-2 but not TNF gene transcription. Interestingly, this inhibition correlates with the effect of the viral protein on the transactivation of the CD28RE/AP1 composite element (-164/-154), but not with that observed on the NFAT/AP1 site of the IL-2 gene promoter, neither with the effect on NF-kappa B- nor AP1-independent binding sites. Endogenous expression of Tat induced a decrease in the amount of the specific protein complex bound to the CD28RE/AP1 probe after PMA plus calcium ionophore stimulation. This effect was accompanied by qualitative alterations of the AP1 complex. Thus, in wild-type Jurkat cells, c-jun was absent from the complex, whereas in Tat-expressing cells, c-jun was increasingly recruited overtime. By contrast, similar amounts of c-rel and a small amount of NFAT1 were detected both in wild type and in Jurkat Tat(+) cells. Furthermore, Tat not only induced the participation of c-jun in the cooperative complex but also a decrease in its transactivation activity alone or in combination with c-rel. Thus, the interaction of Tat with the components of this rel/AP1 cooperative complex seems to induce quantitative and qualitative alterations of this complex as activation progresses, resulting in a decrease of IL-2 gene transcription. Altogether our results suggest the existence of tuned mechanisms that allow the viral protein to specifically affect cooperative interactions between transcription factors.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites / genetics
  • Binding Sites / immunology
  • CD28 Antigens / genetics
  • CD28 Antigens / metabolism*
  • COS Cells
  • DNA-Binding Proteins / metabolism
  • DNA-Binding Proteins / physiology
  • Down-Regulation / immunology
  • Gene Products, tat / biosynthesis
  • Gene Products, tat / physiology*
  • HIV-1 / immunology
  • Humans
  • Interleukin-2 / antagonists & inhibitors*
  • Interleukin-2 / biosynthesis
  • Interleukin-2 / genetics*
  • Interleukin-2 / metabolism
  • Jurkat Cells / immunology
  • Jurkat Cells / metabolism
  • Kinetics
  • NF-kappa B / metabolism
  • NFATC Transcription Factors
  • Nuclear Proteins*
  • Promoter Regions, Genetic / immunology*
  • Proto-Oncogene Proteins c-jun / genetics
  • Proto-Oncogene Proteins c-jun / metabolism
  • Proto-Oncogene Proteins c-rel / genetics
  • Proto-Oncogene Proteins c-rel / metabolism*
  • Proto-Oncogene Proteins c-rel / physiology
  • Response Elements / immunology*
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Transcription Factor AP-1 / genetics
  • Transcription Factor AP-1 / metabolism*
  • Transcription Factor AP-1 / physiology
  • Transcription Factors / metabolism
  • Transcription Factors / physiology
  • Transcription, Genetic / immunology*
  • Transcriptional Activation / immunology
  • tat Gene Products, Human Immunodeficiency Virus

Substances

  • CD28 Antigens
  • DNA-Binding Proteins
  • Gene Products, tat
  • Interleukin-2
  • NF-kappa B
  • NFATC Transcription Factors
  • NFATC2 protein, human
  • Nuclear Proteins
  • Proto-Oncogene Proteins c-jun
  • Proto-Oncogene Proteins c-rel
  • Transcription Factor AP-1
  • Transcription Factors
  • tat Gene Products, Human Immunodeficiency Virus